{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:29:15Z","timestamp":1792592955279,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ejogrb.2023.04.014","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T11:10:37Z","timestamp":1681902637000},"page":"10-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["The efficacy of human papillomavirus prophylactic vaccination after conization in preventing cervical intraepithelial neoplasia recurrence: A prospective observational study in China"],"prefix":"10.1016","volume":"286","author":[{"given":"Ming","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiulin","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengli","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peisong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuzhong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2023.04.014_b0005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bpobgyn.2017.08.015","article-title":"The natural history of human papillomavirus infection","volume":"47","author":"de Sanjos\u00e9","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.04.014_b0010","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","article-title":"Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis","volume":"8","author":"Arbyn","year":"2020","journal-title":"Lancet Glob Health"},{"issue":"9895","key":"10.1016\/j.ejogrb.2023.04.014_b0015","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0140-6736(13)60022-7","article-title":"Human papillomavirus and cervical cancer","volume":"382","author":"Crosbie","year":"2013","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.04.014_b0020","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1017\/S0950268815002198","article-title":"Prophylactic HPV vaccination: past, present, and future","volume":"144","author":"Castle","year":"2016","journal-title":"Epidemiol Infect"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.04.014_b0025","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ygyno.2018.08.033","article-title":"SPERANZA project: HPV vaccination after treatment for CIN2","volume":"151","author":"Ghelardi","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.04.014_b0030","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1186\/s12879-020-05560-z","article-title":"Impact of HPV-16\/18 AS04-adjuvanted vaccine on preventing subsequent infection and disease after excision treatment: post-hoc analysis from a randomized controlled trial","volume":"20","author":"Zhao","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ejogrb.2023.04.014_b0035","doi-asserted-by":"crossref","unstructured":"Hildesheim A, Gonzalez P, Kreimer AR, Wacholder S, Schussler J, Rodriguez AC, et al. Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment. Am J Obstet Gynecol. 2016 Aug;215(2):212.e1-212.e15.","DOI":"10.1016\/j.ajog.2016.02.021"},{"key":"10.1016\/j.ejogrb.2023.04.014_b0040","doi-asserted-by":"crossref","unstructured":"Nayar R, Wilbur DC. The Bethesda System for Reporting Cervical Cytology. Anal Cytology. 2015;10.1007\/978-3-319-11074-5(Chapter 8):263-85.","DOI":"10.1007\/978-3-319-11074-5_8"},{"issue":"7","key":"10.1016\/j.ejogrb.2023.04.014_b0045","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/cncr.32003","article-title":"The distribution and prevalence of human papillomavirus in women in mainland China","volume":"125","author":"Li","year":"2019","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.04.014_b0050","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/1471-0528.15996","article-title":"Long-term predictors of residual or recurrent cervical intraepithelial neoplasia 2\u20133 after treatment with a large loop excision of the transformation zone: a retrospective study","volume":"127","author":"Fern\u00e1ndez-Montol\u00ed","year":"2020","journal-title":"BJOG"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.04.014_b0055","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ygyno.2020.08.025","article-title":"Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser Conization: A 5-year follow-up study","volume":"159","author":"Bogani","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.ejogrb.2023.04.014_b0060","first-page":"S33","article-title":"HPV vaccination: The most pragmatic cervical cancer primary prevention strategy","volume":"131","author":"Sankaranarayanan","year":"2015","journal-title":"Int J Gynaecol Obstet"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.04.014_b0065","doi-asserted-by":"crossref","first-page":"262","DOI":"10.5694\/mja16.00958","article-title":"HPV vaccine coverage is increasing in Australia","volume":"206","author":"Brotherton","year":"2017","journal-title":"Med J Aust"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.04.014_b0070","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/infdis\/jiy249","article-title":"The impact of the National HPV vaccination program in England using the bivalent HPV vaccine: surveillance of type-specific HPV in young females, 2010\u20132016","volume":"218","author":"Mesher","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ejogrb.2023.04.014_b0075","article-title":"On imported and domestic human papillomavirus vaccines: cognition, attitude, and willingness to pay in Chinese Medical Students","volume":"10","author":"Zhou","year":"2022","journal-title":"Front Public Health"},{"issue":"7","key":"10.1016\/j.ejogrb.2023.04.014_b0080","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/jog.14276","article-title":"Advances in therapeutic vaccines for treating human papillomavirus-related cervical intraepithelial neoplasia","volume":"46","author":"Barra","year":"2020","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.ejogrb.2023.04.014_b0085","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.canlet.2019.11.039","article-title":"Human papillomavirus vaccine against cervical cancer: Opportunity and challenge","volume":"471","author":"Wang","year":"2020","journal-title":"Cancer Lett"},{"issue":"6","key":"10.1016\/j.ejogrb.2023.04.014_b0090","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ijgc-2020-001197","article-title":"Prophylactic human papillomavirus vaccination to prevent recurrence of cervical intraepithelial neoplasia: a meta-analysis","volume":"30","author":"Bartels","year":"2020","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"10.1016\/j.ejogrb.2023.04.014_b0095","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/AOG.0000000000003833","article-title":"Adjuvant human papillomavirus vaccine to reduce recurrent cervical dysplasia in unvaccinated women: A systematic review and meta-analysis","volume":"135","author":"Lichter","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"41","key":"10.1016\/j.ejogrb.2023.04.014_b0100","doi-asserted-by":"crossref","first-page":"6402","DOI":"10.1016\/j.vaccine.2020.07.055","article-title":"Prophylactic HPV vaccination after conization: A systematic review and meta-analysis","volume":"38","author":"Jentschke","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.ejogrb.2023.04.014_b0105","doi-asserted-by":"crossref","first-page":"e1401","DOI":"10.1136\/bmj.e1401","article-title":"Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data","volume":"344","author":"Joura","year":"2012","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.ejogrb.2023.04.014_b0110","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1002\/ijc.30391","article-title":"Prior human papillomavirus-16\/18 AS04-adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: post-hoc analysis from a randomized controlled trial","volume":"139","author":"Garland","year":"2016","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.04.014_b0115","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3390\/vaccines8020245","article-title":"HPV vaccination as adjuvant to conization in women with cervical intraepithelial neoplasia: A study under real-life conditions","volume":"8","author":"Del Pino","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"3","key":"10.1016\/j.ejogrb.2023.04.014_b0120","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/ijc.32752","article-title":"Risk of cervical intraepithelial neoplasia grade 2 or worse after conization in relation to HPV vaccination status","volume":"147","author":"Sand","year":"2020","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.04.014_b0125","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/vaccines8010045","article-title":"Efficacy of HPV vaccination in women receiving LEEP for cervical dysplasia: A single institution's experience","volume":"8","author":"Petrillo","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.04.014_b0130","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/LGT.0000000000000625","article-title":"Efficacy of human papillomavirus vaccination 4 years after conization for high-grade cervical neoplasia","volume":"25","author":"G\u00f3mez de la Rosa","year":"2021","journal-title":"J Low Genit Tract Dis"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.04.014_b0135","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3390\/vaccines10020288","article-title":"Effectiveness of prophylactic human papillomavirus vaccine in the prevention of recurrence in women conized for HSIL\/CIN 2\u20133: The VENUS study","volume":"10","author":"Casajuana-P\u00e9rez","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.04.014_b0140","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ygyno.2013.04.050","article-title":"Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2-3)?","volume":"130","author":"Kang","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2023.04.014_b0145","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejogrb.2021.11.008","article-title":"If prophylactic HPV vaccination is considered in a woman with CIN2+, what is the value and should it be given before or after the surgical treatment?","volume":"269","author":"Tjalma","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"11","key":"10.1016\/j.ejogrb.2023.04.014_b0150","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3389\/fimmu.2020.00188","article-title":"The use of both therapeutic and prophylactic vaccines in the therapy of papillomavirus disease","volume":"18","author":"Garbuglia","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ejogrb.2023.04.014_b0155","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jri.2015.01.002","article-title":"Influence of a loop electrosurgical excision procedure (LEEP) on levels of cytokines in cervical secretions","volume":"109","author":"Saftlas","year":"2015","journal-title":"J Reprod Immunol"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211523001616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211523001616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:59:47Z","timestamp":1759557587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211523001616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":31,"alternative-id":["S0301211523001616"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2023.04.014","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy of human papillomavirus prophylactic vaccination after conization in preventing cervical intraepithelial neoplasia recurrence: A prospective observational study in China","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2023.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}